Overview
Prof. YiLong Wu is a world-renowned leader in lung cancer research. He is the Tenured Director of Guangdong Provincial People's Hospital, Honorary Director of the Guangdong Lung Cancer Institute, and President of the Chinese Thoracic Oncology Group (CTONG). As a pioneer of precision medicine and evidence-based medicine in China, he served as the President of CSCO and was the first Chinese recipient of the IASLC Paul A. Bunn Jr. Scientific Award.
Clinical focus & conditions
Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)
Thoracic tumors
Mediastinal tumors
lung cancers with rare molecular targets
Education & training
MD,Ph.D. — Sun Yat-sen University
Training — Berlin Pulmonary Hospital, Germany
Fellow of the American College of Surgeons (FACS)
Hospital affiliations
Guangdong Provincial People's Hospital
Honors & Research
Honors:
1. State Science and Technology Progress Award (Second Class).
2. IASLC Paul A. Bunn Jr. Scientific Award.
3.Highly Cited Researcher (2018-2021).
Research:
Led landmark studies (e.g., IPASS, ALINA) that redefined global treatment guidelines; published 400+ papers in top journals like NEJM, The Lancet, and JCO.
Is my case a fit for a second opinion?
A second opinion is often helpful if you have a new diagnosis multiple treatment options discordant pathology or imaging results progression/recurrence or you want confirmation before starting therapy.
•Good fit: complex decisions uncertainty multiple lines of therapy clinical trial questions.
•Not a fit: emergencies (e.g. severe symptoms acute complications). Seek urgent local care.
Important note
This page is for educational and second-opinion purposes. It is not a substitute for emergency care or an in-person exam. If you have urgent symptoms, contact local emergency services.